Asia Pacific Menopause Federation Menopause Consensus

Sponsor

Singapore General Hospital (Other)

Overall Status

Recruiting

CT.gov ID

NCT06048965

Collaborator

(none)

Enrollment

Location

Anticipated Duration (Months)

1.7

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific

Condition or Disease	Intervention/Treatment	Phase
Menopause Menopause Related Conditions	Other: No intervention to be performed

Detailed Description

The aim of this study is to achieve expert consensus on the management of menopause in the Asia-Pacific. The experience of the menopause is deeply rooted in sociocultural perceptions unique to each population. Thus, the management of menopausal symptoms and other conditions related to the menopause also vary from region to region.

The investigators will use a modified Delphi method involving the participation of experts from various countries in the Asia-Pacific. The objective of this study is to achieve consensus on various aspects of the management of the menopause in the Asia-Pacific.

This study will involve several rounds of Delphi surveys, administered via Google Forms. Each survey questionnaire contains

Questions on basic demographic information
Statements on areas of concern in the management of the menopause; each participants vote on to what extent they agree or disagree with the statement on a Likert scale.
Questions on the participants' usual clinical practice in treating menopause Multiple survey rounds will be held until agreement on the statements and stability is achieved.

Study Design

Study Type:

Observational

Anticipated Enrollment :

30 participants

Observational Model:

Other

Time Perspective:

Prospective

Official Title:

An Expert Panel Consensus Statement on the Management of Menopause in the Asia-Pacific Using Modified Delphi Methodology

Anticipated Study Start Date :

Sep 15, 2023

Anticipated Primary Completion Date :

Sep 15, 2024

Anticipated Study Completion Date :

Mar 15, 2025

Arms and Interventions

Arm	Intervention/Treatment
Expert group	Other: No intervention to be performed No intervention to be performed. Anonymous survey only.

Arm

Intervention/Treatment

Expert group

Other: No intervention to be performed

No intervention to be performed. Anonymous survey only.

Outcome Measures

Primary Outcome Measures

Percentage of participants who vote for the same option on a series of survey questions [2023-2024]

Eligibility Criteria

Criteria

Ages Eligible for Study:

21 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

Experience in treating menopause

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	KK Hospital	Singapore		Singapore	229899

Sponsors and Collaborators

Singapore General Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Singapore General Hospital

ClinicalTrials.gov Identifier:

NCT06048965

Other Study ID Numbers:

APMFMenopause2023

First Posted:

Sep 21, 2023

Last Update Posted:

Sep 21, 2023

Last Verified:

Sep 1, 2023

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Study Results

No Results Posted as of Sep 21, 2023